Jubilant Pharmova Ltd (530019) Stock Price & News

530019:BOM

Jubilant Pharmova Ltd

₹935.15

+0.31%

(+2.90) 1D

Oct 9, 2:24:11 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 530019...

Open

₹938.30

High

₹939.75

Low

₹918.00

Mkt. cap

148.47B

Avg. vol.

18.02K

Volume

157.16K

Dividend

0.53%

Quarterly dividend

₹1.25

Ex-dividend date

Jul 24, 2026

P/E ratio

42.18

52-wk high

₹1,183.90

52-wk low

₹783.75

EPS

₹22.17

No. of employees

Open

₹938.30

High

₹939.75

Low

₹918.00

Mkt. cap

148.47B

Avg. vol.

18.02K

Volume

157.16K

Dividend

0.53%

Quarterly dividend

₹1.25

Ex-dividend date

Jul 24, 2026

P/E ratio

42.18

52-wk high

₹1,183.90

52-wk low

₹783.75

EPS

₹22.17

No. of employees

Related stocks

JUBLPHARMA

Jubilant Pharmova Ltd

Neuland Laboratories Ltd

₹20,920.00

-0.45%

News stories

From web sources and news partners

Trade Brains

3 hours ago

Jubilant Pharmova in focus as Radiopharma arm to invest CAD 94.5 Million in Canada plant expansion

Sahi

7 hours ago

Jubilant Pharmova Announces CAD 94.5 Million Investment To Double Ruby-Fill Production Capacity

TipRanks

13 hours ago

Jubilant Pharmova to Double RUBY-FILL Capacity with CAD 94.5 Million Québec Expansion

EquityBulls

14 hours ago

Jubilant's Radiopharma business announces investment of CAD 94.5 million to double production capacity of its flagship product, RUBY-FILL

About Jubilant Pharmova Ltd

CEO-

Employees5.66K

Founded1978

HeadquartersNoida, Uttar Pradesh, India

SectorPharmaceutical industry

Websitejubilantpharmova.com

All values in INR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	19.66B	21.22B	22.90B	22.29B
Cost of goods sold	5.96B	7.16B	9.53B	7.49B
Cost of revenue	5.96B	7.16B	9.53B	7.49B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.36B	7.06B	8.34B	7.54B
Operating expense	11.33B	12.37B	11.14B	13.60B
Total operating expenses	17.30B	19.54B	20.68B	21.09B
Operating income	2.37B	1.69B	2.22B	1.21B
Other non operating income	98.00M	205.00M	-369.00M	199.00M
EBT including unusual items	1.90B	934.00M	1.76B	864.00M
EBT excluding unusual items	1.96B	1.33B	1.87B	864.00M
Income tax expense	704.00M	376.00M	567.00M	300.00M
Effective tax rate	36.99%	40.26%	32.22%	34.72%
Other operating expenses	3.92B	4.10B	1.63B	4.79B
Net income	1.20B	559.00M	1.19B	565.00M
Net profit margin	6.12%	2.63%	5.21%	2.53%
Earnings per share	7.85	5.01	8.10	3.56
Interest and investment income	-	-	252.00M	-
Interest expense	-502.00M	-561.00M	-461.00M	-542.00M
Net interest expenses	-502.00M	-561.00M	-209.00M	-542.00M
Depreciation and amortization charges	1.05B	1.21B	1.17B	1.27B
EBITDA	3.38B	2.30B	2.98B	1.96B
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything